Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantationPeter J. Darlington, Ho Jin Kim, Martin Duddy et al.|Annals of Neurology|2012Cited by 152
Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosisPeter J. Darlington, Amit Bar‐Or, Marie‐Noëlle Boivin et al.|Annals of Neurology|2010Cited by 80
Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple SclerosisPeter J. Darlington, Amit Bar‐Or, Brandon Stopnicki et al.|Frontiers in Immunology|2018Cited by 77
The β2-adrenergic biased agonist nebivolol inhibits the development of Th17 and the response of memory Th17 cells in an NF-κB-dependent mannerMehri Hajiaghayi, Peter J. Darlington|Frontiers in Immunology|2024Cited by 3